|
1
|
Subramani R, Lopez-Valdez R, Arumugam A,
Nandy S, Boopalan T and Lakshmanaswamy R: Targeting insulin-like
growth factor 1 receptor inhibits pancreatic cancer growth and
metastasis. PLoS One. 9:e970162014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
McGuigan A, Kelly P, Turkington RC, Jones
C, Coleman HG and McCain RS: Pancreatic cancer: A review of
clinical diagnosis, epidemiology, treatment and outcomes. World J
Gastroenterol. 24:4846–4861. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Razidlo GL, Magnine C, Sletten AC, Hurley
RM, Almada LL, Fernandez-Zapico ME, Ji B and McNiven MA: Targeting
Pancreatic Cancer Metastasis by Inhibition of Vav1, a Driver of
Tumor Cell Invasion. Cancer Res. 75:2907–2915. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang H and Chen L: Tumor microenviroment
and hepatocellular carcinoma metastasis. J Gastroenterol Hepatol.
28(Suppl 1): 43–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kahlert C and Kalluri R: Exosomes in tumor
microenvironment influence cancer progression and metastasis. J Mol
Med (Berl). 91:431–437. 2013. View Article : Google Scholar
|
|
6
|
Gajos-Michniewicz A, Duechler M and Czyz
M: MiRNA in melanoma-derived exosomes. Cancer Lett. 347:29–37.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li L, Li C, Wang S, Wang Z, Jiang J, Wang
W, Li X, Chen J, Liu K, Li C, et al: Exosomes Derived from Hypoxic
Oral Squamous Cell Carcinoma Cells Deliver miR-21 to Normoxic Cells
to Elicit a Prometastatic Phenotype. Cancer Res. 76:1770–1780.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liao J, Liu R, Shi YJ, Yin LH and Pu YP:
Exosome-shuttling microRNA-21 promotes cell migration and
invasion-targeting PDCD4 in esophageal cancer. Int J Oncol.
48:2567–2579. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Takikawa T, Masamune A, Yoshida N, Hamada
S, Kogure T and Shimosegawa T: Exosomes Derived From Pancreatic
Stellate Cells: MicroRNA Signature and Effects on Pancreatic Cancer
Cells. Pancreas. 46:19–27. 2017. View Article : Google Scholar
|
|
10
|
Ali S, Suresh R, Banerjee S, Bao B, Xu Z,
Wilson J, Philip PA, Apte M and Sarkar FH: Contribution of
microRNAs in understanding the pancreatic tumor microenvironment
involving cancer associated stellate and fibroblast cells. Am J
Cancer Res. 5:1251–1264. 2015.PubMed/NCBI
|
|
11
|
Charrier A, Chen R, Chen L, Kemper S,
Hattori T, Takigawa M and Brigstock DR: Connective tissue growth
factor (CCN2) and microRNA-21 are components of a positive feedback
loop in pancreatic stellate cells (PSC) during chronic pancreatitis
and are exported in PSC-derived exosomes. J Cell Commun Signal.
8:147–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bachem MG, Schneider E, Gross H,
Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A and
Adler G: Identification, culture, and characterization of
pancreatic stellate cells in rats and humans. Gastroenterology.
115:421–432. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Au Yeung CL, Co NN, Tsuruga T, Yeung TL,
Kwan SY, Leung CS, Li Y, Lu ES, Kwan K, Wong KK, et al: Exosomal
transfer of stroma-derived miR21 confers paclitaxel resistance in
ovarian cancer cells through targeting APAF1. Nat Commun.
7:111502016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi BVSK and
Varambally S: UALCAN: A portal for facilitating tumor subgroup gene
expression and survival analyses. Neoplasia. 19:649–658. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Langfelder P and Horvath S: WGCNA.an R
package for weighted correlation network analysis. BMC
Bioinformatics. 9:5592008. View Article : Google Scholar
|
|
16
|
Xu Y, Li H, Huang C, Zhao T, Zhang H,
Zheng C, Ren H and Hao J: Wnt2 protein plays a role in the
progression of pancreatic cancer promoted by pancreatic stellate
cells. Med Oncol. 32:972015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wrighton KH: Cell migration: EMT promotes
contact inhibition of locomotion. Nat Rev Mol Cell Biol.
16:5182015. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
El-Ghlban S, Kasai T, Shigehiro T, Yin HX,
Sekhar S, Ida M, Sanchez A, Mizutani A, Kudoh T, Murakami H, et al:
Chlorotoxin-Fc fusion inhibits release of MMP-2 from pancreatic
cancer cells. BioMed Res Int. 2014:1526592014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu LF, Wu ZP, Chen Y, Zhu QS, Hamidi S and
Navab R: MicroRNA-21 (miR-21) regulates cellular proliferation,
invasion, migration, and apoptosis by targeting PTEN, RECK and
Bcl-2 in lung squamous carcinoma, Gejiu City, China. PLoS One.
9:e1036982014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Jiao Y, Fu Z, Li Y, Meng L and Liu Y: High
EIF2B5 mRNA expression and its prognostic significance in liver
cancer: A study based on the TCGA and GEO database. Cancer Manag
Res. 10:6003–6014. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: An open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Szklarczyk D, Morris JH, Cook H, Kuhn M,
Wyder S, Simonovic M, Santos A, Doncheva NT, Roth A, Bork P, et al:
The STRING database in 2017: Quality-controlled protein-protein
association networks, made broadly accessible. Nucleic Acids Res.
45(D1): D362–D368. 2017. View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: AAnalysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
24
|
Tiwari P, Sahay S, Pandey M, Qadri SS and
Gupta KP: Preventive effects of butyric acid, nicotinamide, calcium
glucarate alone or in combination during the 7, 12-dimethylbenz (a)
anthracene induced mouse skin tumorigenesis via modulation of
K-Ras-PI3K-AKTpathway and associated micro RNAs. Biochimie.
121:112–122. 2016. View Article : Google Scholar
|
|
25
|
Nussinov R, Muratcioglu S, Tsai CJ, Jang
H, Gursoy A and Keskin O: The Key Role of Calmodulin in KRAS-Driven
Adenocarcinomas. Mol Cancer Res. 13:1265–1273. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vena F, Li Causi E, Rodriguez-Justo M,
Goodstal S, Hagemann T, Hartley JA and Hochhauser D: The MEK1/2
Inhibitor Pimasertib Enhances Gemcitabine Efficacy in Pancreatic
Cancer Models by Altering Ribonucleotide Reductase Subunit-1
(RRM1). Clin Cancer Res. 21:5563–5577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sahu N, Chan E, Chu F, Pham T, Koeppen H,
Forrest W, Merchant M and Settleman J: Co-targeting of MEK and
PDGFR/STAT3 pathways to treat pancreaticductal adenocar-cinoma. Mol
Cancer Ther. 16:1729–1738. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xu Z, Vonlaufen A, Phillips PA, Fiala-Beer
E, Zhang X, Yang L, Biankin AV, Goldstein D, Pirola RC, Wilson JS,
et al: Role of pancreatic stellate cells in pancreatic cancer
metastasis. Am J Pathol. 177:2585–2596. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Z, Pothula SP, Wilson JS and Apte MV:
Pancreatic cancer and its stroma: A conspiracy theory. World J
Gastroenterol. 20:11216–11229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Masamune A and Shimosegawa T: Pancreatic
stellate cells: A dynamic player of the intercellular communication
in pancreatic cancer. Clin Res Hepatol Gastroenterol. 39(Suppl 1):
S98–S103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Prakash J: Cancer-Associated Fibroblasts:
Perspectives in Cancer Therapy. Trends Cancer. 2:277–279. 2016.
View Article : Google Scholar
|
|
32
|
Hu Y, Yan C, Mu L, Huang K, Li X, Tao D,
Wu Y and Qin J: Fibroblast-Derived Exosomes Contribute to
Chemoresistance through Priming Cancer Stem Cells in Colorectal
Cancer. PLoS One. 10:e01256252015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Donnarumma E, Fiore D, Nappa M, Roscigno
G, Adamo A, Iaboni M, Russo V, Affinito A, Puoti I, Quintavalle C,
et al: Cancer-associated fibroblasts release exosomal microRNAs
that dictate an aggressive phenotype in breast cancer. Oncotarget.
8:19592–19608. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Forterre A, Jalabert A, Chikh K, Pesenti
S, Euthine V, Granjon A, Errazuriz E, Lefai E, Vidal H and Rome S:
Myotube-derived exosomal miRNAs downregulate Sirtuin1 in myoblasts
during muscle cell differentiation. Cell Cycle. 13:78–89. 2014.
View Article : Google Scholar :
|
|
35
|
Gao W, Xu J, Liu L, Shen H, Zeng H and Shu
Y: A systematic-analysis of predicted miR-21 targets identifies a
signature for lung cancer. Biomed Pharmacother. 66:21–28. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar :
|
|
37
|
Pfeffer SR, Yang CH and Pfeffer LM: The
Role of miR-21 in Cancer. Drug Dev Res. 76:270–277. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sharma SB, Lin CC, Farrugia MK, McLaughlin
SL, Ellis EJ, Brundage KM, Salkeni MA and Ruppert JM: MicroRNAs 206
and 21 cooperate to promote RAS-extracellular signal-regulated
kinase signaling by suppressing the translation of RASA1 and
SPRED1. Mol Cell Biol. 34:4143–4164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Liu H, Huang X, Liu X, Xiao S, Zhang Y,
Xiang T, Shen X, Wang G and Sheng B: miR-21 promotes human nucleus
pulposus cell proliferation through PTEN/AKT signaling. Int J Mol
Sci. 15:4007–4018. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang L, Yao J, Li W and Zhang C:
Micro-RNA-21 Regulates Cancer-Associated Fibroblast-Mediated Drug
Resistance in Pancreatic Cancer. Oncol Res. 26:827–835. 2018.
View Article : Google Scholar
|
